Sleuthing molecular targets for neurological diseases at the neuromuscular junction.
Engel
Andrew G
AG
Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, Minnesota 55905, USA. age@mayo.edu
Ohno
Kinji
K
Sine
Steven M
SM
D000110:Acetylcholinesterase / Q000235:genetics / Q000378:metabolism; D000818:Animals; D002795:Choline O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D004594:Electrophysiology; D006801:Humans; D009124:Muscle Proteins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D020294:Myasthenic Syndromes, Congenital / Q000235:genetics / Q000378:metabolism*; D009469:Neuromuscular Junction / Q000502:physiology*; D011487:Protein Conformation; D011950:Receptors, Cholinergic / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D009435:Synaptic Transmission / Q000502:physiology
D009124:Muscle Proteins; D011950:Receptors, Cholinergic; C051609:peripheral membrane protein 43K; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase